SCBE In The News
David Magnus, the Thomas A. Raffin Professor and director of the Stanford Center for Biomedical Ethics, was interviewed during a segment about a patient who was denied a chemotherapy drug because it was too expensive.
Inside Higher Ed, 02/16/12
--Ethics in bioethics
David Magnus, the Thomas A. Raffin Professor and director of the Stanford Center for Biomedical Ethics, is quoted in this piece about Glenn McGee, a prominent bioethicist, who recently joined a for-profit stem-cell company while remaining editor of the American Journal of Bioethics.
San Jose Mercury News, 02/24/12
--Simple, early blood test tells fetal health, replacing intrusive tests
A Stanford-created non-invasive blood test that can detect Down syndrome and two other major genetic defects very early in a woman's pregnancy will be available beginning March 1. Stephen Quake, the Lee Otterson Professor of Bioengineering, who was involved in the development of these prenatal tests, is quoted in this article. Hank Greely, with the Stanford Center for Biomedical Ethics, also provides comment.
Harvard researchers have discovered the ovaries of young women harbor very rare stem cells capable of producing new eggs. Hank Greely, with the Stanford Center for Biomedical Ethics, provided commentary during this segment.